Anchalee Avihingsanon

Summary

Affiliation: The HIV Netherlands Australia Thailand Research Collaboration
Country: Thailand

Publications

  1. ncbi Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study
    Anchalee Avihingsanon
    HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center, Pathumwan, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:1170-6. 2012
  2. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
  3. doi Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand
    Anchalee Avihingsanon
    HIV NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    Antivir Ther 15:917-22. 2010
  4. doi Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals
    Jasper van der Lugt
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, Thai Red Cross Aids Research Centre TRCARC, Bangkok, Thailand
    Antivir Ther 14:1001-4. 2009
  5. doi Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals
    Jasper van der Lugt
    The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
    AIDS 23:1176-9. 2009
  6. doi Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy
    Reshmie A Ramautarsing
    The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
    AIDS 25:1299-303. 2011
  7. pmc Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients
    Anchalee Avihingsanon
    1 HIV Netherlands Australia Thailand HIV NAT Research Collaboration, Thai Red Cross AIDS Research Center Bangkok, Bangkok, Thailand
    AIDS Res Hum Retroviruses 29:1541-6. 2013
  8. doi Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients
    Reshmie A Ramautarsing
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, Bangkok, Thailand
    Antivir Ther 18:249-52. 2013
  9. pmc Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy
    Jintanat Ananworanich
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    Antimicrob Agents Chemother 56:1892-8. 2012
  10. doi Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy
    Denise C Hsu
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand Electronic address
    J Infect 68:344-54. 2014

Collaborators

Detail Information

Publications30

  1. ncbi Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study
    Anchalee Avihingsanon
    HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center, Pathumwan, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:1170-6. 2012
    ..Despite good virological outcome in our cohort, prolonged exposure to subtherapeutic indinavir concentrations may lead to treatment failure...
  2. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
    ..abstract:..
  3. doi Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand
    Anchalee Avihingsanon
    HIV NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    Antivir Ther 15:917-22. 2010
    ..However, there is limited randomized data on the efficacy of combined therapy with TDF and FTC, especially in antiretroviral (ARV)-naive patients...
  4. doi Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals
    Jasper van der Lugt
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, Thai Red Cross Aids Research Centre TRCARC, Bangkok, Thailand
    Antivir Ther 14:1001-4. 2009
    ..However quality and safety remains an issue of concern. Therefore, we evaluated minimal plasma concentrations and short-term safety of a generic lopinavir/ritonavir 200/50 mg tablet formulation...
  5. doi Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals
    Jasper van der Lugt
    The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
    AIDS 23:1176-9. 2009
    ..The 50% reduction of ritonavir boosting did not result in a change in the pharmacokinetics of saquinavir, whereas the ritonavir exposure was significantly lower when a dose of 50 mg was administered...
  6. doi Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy
    Reshmie A Ramautarsing
    The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
    AIDS 25:1299-303. 2011
    ..To investigate whether Thai HIV-1-infected pregnant women require a dose increase of lopinavir/ritonavir (LPV/r) and to assess the safety and efficacy of the generic tablets during pregnancy...
  7. pmc Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients
    Anchalee Avihingsanon
    1 HIV Netherlands Australia Thailand HIV NAT Research Collaboration, Thai Red Cross AIDS Research Center Bangkok, Bangkok, Thailand
    AIDS Res Hum Retroviruses 29:1541-6. 2013
    ..Patients from the aging group appeared to have higher atazanavir exposure compared to the younger group. Further PK explorations of ATV in the extremely aged population are warranted...
  8. doi Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients
    Reshmie A Ramautarsing
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, Bangkok, Thailand
    Antivir Ther 18:249-52. 2013
    ..We assessed pharmacokinetics, safety and efficacy of generic lopinavir/ritonavir (LPV/r) produced by the Government Pharmaceutical Organization (GPO) of Thailand in Thai HIV-infected adults...
  9. pmc Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy
    Jintanat Ananworanich
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    Antimicrob Agents Chemother 56:1892-8. 2012
    ..However, raltegravir at 400 mg QD was associated with a low C(trough) and with a risk for HIV viremia. Raltegravir at 200 or 300 mg BID should be studied, but new raltegravir formulations will be needed...
  10. doi Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy
    Denise C Hsu
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand Electronic address
    J Infect 68:344-54. 2014
    ..Despite antiretroviral therapy (ART), HIV-infected persons have increased risk of active tuberculosis (TB). PPD and combined ESAT-6 and CFP-10-specific-CD4 (EC-Sp-CD4) responses were examined over 96 weeks...
  11. doi Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg twice daily
    Reshmie A Ramautarsing
    The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
    J Acquir Immune Defic Syndr 59:55-8. 2012
    ..All patients remained virologically suppressed at week 12. In conclusion, LPV/r 200/50mg BID does not lead to adequate lopinavir plasma concentrations. Generic and branded LPV/r have comparable PK-parameters...
  12. doi Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy
    Anchalee Avihingsanon
    HIV Netherlands Australia Thailand HIV NAT Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    Antivir Ther 19:41-9. 2014
    ..Vitamin D insufficiency plays an important role in the development of fibrosis in chronic liver disease...
  13. doi Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults
    Jasper van der Lugt
    HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center Bangkok, 104 Ratchadamri Road, Pathumwan, Bangkok 10330, Thailand
    J Antimicrob Chemother 61:1145-53. 2008
    ..To study the pharmacokinetics and short-term efficacy of low and standard dose lopinavir/ritonavir and saquinavir combinations in Thai, human immunodeficiency virus (HIV)-infected, treatment-naive patients...
  14. ncbi Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens
    Stephen J Kerr
    The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
    J Int Assoc Physicians AIDS Care (Chic) 6:36-46. 2007
    ..Non-stavudine-containing non-boosted protease-inhibitor-based highly active antiretroviral treatment regimens had the least association with dyslipidemia...
  15. pmc Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
    Amanda Clarke
    The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, Thai Red Cross AIDS Research Centre, 104 Ratchadamri Road, Bangkok 10330, Thailand
    Open Virol J 6:23-8. 2012
    ..Nonetheless condom negotiation techniques, particularly in women, may be useful in this group...
  16. doi Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227
    K Ruxrungtham
    HIV NAT, Thai Red Cross AIDS Research Center and Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    HIV Med 9:883-96. 2008
    ....
  17. doi Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels
    Anchalee Avihingsanon
    HIV Netherlands Australia Thailand Research Collaboration HIV NAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand Division of Allergy and Immunology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    J Gastroenterol Hepatol 29:1706-14. 2014
    ..We assessed liver fibrosis by transient elastography and 25 hydroxy vitamin D [25(OH)D] status in HCV-infected patients, with (HIV/HCV) or without HIV co-infection (HCV) from Thailand...
  18. doi Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected Thais
    Nadia Kancheva Landolt
    a The HIV Netherlands Australia Thailand Research Collaboration HIV NAT, Bangkok, Thailand
    AIDS Care 27:587-94. 2015
    ..This could be a powerful tool for effective fight against stigma and self-stigma in people living with HIV. ..
  19. doi Treatment of HIV infection with once-daily regimens
    Nitipong Permpalung
    Chulalongkorn University, Faculty of Medicine, Department of Medicine, Bangkok, Thailand
    Expert Opin Pharmacother 13:2301-17. 2012
    ..Treatment for HIV infection requires a lifetime antiretroviral therapy. In order to improve adherence, once daily (OD) is thus a preferred regimen...
  20. ncbi Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin
    Anchalee Avihingsanon
    HIV NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    Antivir Ther 13:529-36. 2008
    ..We aim here to determine the appropriate dose of nevirapine (NVP) in Thai HIV-tuberculosis (TB)-coinfected patients receiving rifampicin...
  21. doi Feasibility and efficacy of isoniazid prophylaxis for latent tuberculosis in HIV-infected clients patients in Thailand
    Mana Khongphatthanayothin
    Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:270-5. 2012
    ..However, the long-term advantage of INH prophylaxis in terms of TB prevention, especially in HIV-1-infected patients on highly active antiretroviral therapy (HAART), is still an issue that needs more research...
  22. doi Factors associated with daily tenofovir exposure in thai subjects taking combination antiretroviral therapy
    Stephen J Kerr
    1 HIV NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    AIDS Res Hum Retroviruses 31:368-74. 2015
    ..Clinicians should be aware of the effect of these factors on TFV exposure when this drug is prescribed. ..
  23. pmc Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency
    Denise C Hsu
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    PLoS ONE 8:e77479. 2013
    ..This study characterized the dynamics of CMV-Sp-CD4 after ART initiation and explored associations with CD4 T cell recovery as well as frequency of naïve CD4 T cells at week 96...
  24. doi Impact of baseline virologic, immunologic, and demographic characteristics on virologic responses in the Gemini study
    Anchalee Avihingsanon
    HIV Netherlands Australia Thailand, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    HIV Clin Trials 13:111-7. 2012
    ..To determine the impact of baseline viral load (VL) and CD4+ cell count, race/ethnicity, and gender on response in a post hoc analysis of the Gemini study...
  25. doi The Correlation between Hepatitis C Core Antigen and Hepatitis C Virus RNA Levels with Respect to Human Immunodeficiency Virus Status, Hepatitis C Virus Genotype and Interferon-Lambda-4 Polymorphism
    Vo Duy Thong
    Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    Intervirology 58:73-9. 2015
    ..Data in HCV/HIV coinfected patients are still limited. We aim to compare the use of HCVcAg measurement with respect to HIV status, HCV genotypes, interferon-lambda-4 (IFNL4) polymorphism and clinical parameters...
  26. doi Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencing
    Pisit Tangkijvanich
    Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    J Med Virol 85:16-25. 2013
    ..There was no major difference in the frequencies of common HBV mutations between co-infected and mono-infected patients. Thus, HBV mutations may not contribute to disease pathogenesis in Thai patients with co-infection...
  27. doi Active voluntary counseling and testing with integrated CD4 count service can enhance early HIV testing and early CD4 count measurement: experiences from the Thai Red Cross Anonymous Clinic in Bangkok, Thailand
    Nittaya Phanuphak
    The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
    J Acquir Immune Defic Syndr 56:244-52. 2011
    ..Active voluntary counseling and testing (VCT) center with integrated CD4 count service may facilitate early HIV testing and CD4 count measurement...
  28. doi Population pharmacokinetics of nevirapine in Thai HIV-infected patients
    Thanaporn Wattanakul
    Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
    Antivir Ther 19:651-60. 2014
    ..The purpose of the current study was to determine the population mean pharmacokinetic parameters and identify factors that influence pharmacokinetic parameters of nevirapine in Thai HIV-infected patients...
  29. doi HIV and noncommunicable diseases: the Asian perspective
    Jintanat Ananworanich
    US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD HIV NAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand and Division of Allergy and Immunology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    J Acquir Immune Defic Syndr 67:S99-103. 2014
    ..Resource-limited countries in Asia suffer from lack of resources for national screening programs of noncommunicable diseases, which, in turn, limits the epidemiologic data that exist to guide the use of national health resources...
  30. ncbi Ergotism in Thailand caused by increased access to antiretroviral drugs: a global warning
    Anchalee Avihingsanon
    HIV Netherlands Australia Thailand HIV NAT Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand
    Top Antivir Med 21:165-8. 2014
    ..A total of 13 cases of clinical ergotism in HIV-infected patients has been published since 1997 (most recently reviewed by Frohlich et al). ..